Donate
Australian & New Zealand Childrens Haematology/Oncology Group

ANZCHOG Children’s Cancer Clinical Trials Repository

Study Title
An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma
Protocol ID
RG_17-427 (FAR-RMS)
Disease (Sub Disease)
Rhabdomyosarcoma
Diagnosis Stage
Relapsed/ refractory
Location
NSW, VIC, WA, NZ
Sponsor
Australian and New Zealand Children's Haematology Oncology Group
University of Birmingham
Trial Status
Open
Sites
Royal Children's Hospital
Peter MacCallum Cancer Centre
Christchurch Hospital
The Children's Hospital at Westmead
Perth Children's Hospital
Study Type
Treatment
Phase
Phase 1
Age Eligibility
no limits
International registry ID's
NCT04625907
Back to Registry
Study Title An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma
Protocol ID RG_17-427 (FAR-RMS)
Disease (Sub Disease) Rhabdomyosarcoma
Diagnosis Stage Relapsed/ refractory
Location NSW / VIC / WA / NZ
Sponsor Australian and New Zealand Children's Haematology Oncology Group/ University of Birmingham
Links https://clinicaltrials.gov/ct2/show/NCT04625907
Trial Status Open
Trial Open Date 17/09/2020
Sites Royal Children's Hospital / Peter MacCallum Cancer Centre/ Christchurch Hospital/ The Children's Hospital at Westmead/ Perth Children's Hospital
Study Type Treatment
Phase Phase 1
Age Eligibility no limits
International registry ID's NCT04625907